Source |
Code |
Name |
Case count |
Share of cases (%) |
PURCH |
PURCH_ATC(H05BA01) |
Calcitonin (salmon synthetic) |
2369 |
|
OUTPAT |
OUTPAT_ICD10(E2109) |
Other primary hyperparathyroidism |
2094 |
|
OUTPAT |
OUTPAT_ICD10(E210) |
Primary hyperparathyroidism |
1265 |
|
INPAT |
INPAT_ICD10(E2109) |
Other primary hyperparathyroidism |
1251 |
|
OUTPAT |
OUTPAT_ICD10(E213) |
Hyperparathyroidism, unspecified |
801 |
|
PURCH |
PURCH_ATC(H05BX01) |
Cinacalcet |
557 |
|
PRIM_OUT |
PRIM_OUT_NOT_USED_ICD10(E2109) |
Other primary hyperparathyroidism. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! |
538 |
|
INPAT |
INPAT_ICD10(E210) |
Primary hyperparathyroidism |
450 |
|
PRIM_OUT |
PRIM_OUT_NOT_USED_ICD10(E213) |
Hyperparathyroidism, unspecified. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! |
414 |
|
INPAT |
INPAT_ICD10(E213) |
Hyperparathyroidism, unspecified |
372 |
|
OUTPAT |
OUTPAT_ICD10(E212) |
Other hyperparathyroidism |
337 |
|
PRIM_OUT |
PRIM_OUT_NOT_USED_ICD10(E210) |
Primary hyperparathyroidism. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! |
301 |
|
OUTPAT |
OUTPAT_ICD10(E211) |
Secondary hyperparathyroidism, not elsewhere classified |
183 |
|
INPAT |
INPAT_ICD10(E212) |
Other hyperparathyroidism |
137 |
|
PURCH |
PURCH_ATC(H05BX02) |
Paricalcitol |
124 |
|
PRIM_OUT |
PRIM_OUT_NOT_USED_ICD10(E212) |
Other hyperparathyroidism. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! |
91 |
|
INPAT |
INPAT_ICD10(E211) |
Secondary hyperparathyroidism, not elsewhere classified |
88 |
|
INPAT |
INPAT_ICD9(2520A) |
Hyperparathyroidism |
81 |
|
INPAT |
INPAT_ICD8(25200) |
Diseases of parathyroid gland, Hyperparathyroidism |
70 |
|
PRIM_OUT |
PRIM_OUT_NOT_USED_ICD10(E211) |
Secondary hyperparathyroidism, not elsewhere classified. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! |
31 |
|
DEATH |
DEATH_ICD10(E210) |
Primary hyperparathyroidism |
7 |
|